Maze Therapeutics, Inc. · NASDAQ:MAZE
Dandekar Atul sold 6,434 Maze Therapeutics, Inc. shares (Form 4)
Traded Sep 2 to Sep 3, 2026 · Filed Sep 4, 2026
From Sep 2 to Sep 3, 2026, Dandekar Atul (CSBO) sold 6,434 Maze Therapeutics, Inc. shares at an average US$26.24 for US$169K, leaving 32,316 shares. Filed Sep 4, 2026 (Form 4).
- Sold
- 6,434 shares
- Price
- US$26.24 average (US$25.81 to US$27.12)
- Value
- US$169K
- Holding after
- 32,316 shares
- Trading plan
- No
- Role
- CSBO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | Common Stock | Sale | 2,800 | US$26.38 | 35,950 | Direct |
| Sep 2, 2026 | Common Stock | Sale | 391 | US$27.12 | 35,559 | Direct |
| Sep 3, 2026 | Common Stock | Sale | 3,207 | US$26.01 | 32,352 | Direct |
| Sep 3, 2026 | Common Stock | Sale | 36 | US$25.81 | 32,316 | Direct |
Source
Related
- Maze Therapeutics, Inc.
- Dandekar Atul
- Maze Therapeutics, Inc. shareholders
- Form 4 · Dandekar Atul · Oct 1, 2026
- Form 4 · Dandekar Atul · Sep 3, 2026
- Form 4 · Dandekar Atul · Aug 31, 2026
- Form 4 · Dandekar Atul · Jul 31, 2026
- Form 4 · Dandekar Atul · Jul 1, 2026
- Form 4 · Bernstein Harold · Oct 2, 2026
- Form 4 · Coloma Jason V · Oct 2, 2026
- Form 4 · Bernstein Harold · Sep 8, 2026
- Form 4 · Bernstein Harold · Sep 4, 2026
- Form 4 · Coloma Jason V · Sep 4, 2026